Physical tolerance and quality of life in COPD patients. Effects of tiotropium bromide

1. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report, updated 2003.

2. Vincken W., van Noord J., Greefhorst A., et al. Improved health outcome in patients with COPD during lyr's treatment with tiotropium. Eur.Respir. J. 2002; 19: 209-216.

3. Casaburi R., Mahler D., Jones P. et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur. Respir. J. 2002; 19: 217-224.

4. Donohue J.,van Noord J., Bateman E. et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.

5. O'Donnel D., Magnussen H., Aguilaniu B. et al. Spiriva (tiotropium) improves exercise tolerance in COPD. Am. J. Respir. Crit. Care Med. 2002; 165: 227.

6. O'Donnel D., Magnussen H., Gerken F. et al. Mechanisms of improved exercise tolerance in COPD in response to tiotropium. Eur. Respir. J. 2002; 20: 288s.

7. O'Donnel D., Magnussen H., Aguilaniu B. et al. Spiriva (tiotropium) reduces exertional dyspnea in COPD. Am. J. Respir. Crit. Care Med. 2002; 165: A265.